表紙:免疫グロブリンの市場規模:製品タイプ別、投与経路別、用途別、最終用途別、予測、2023年~2032年
市場調査レポート
商品コード
1384345

免疫グロブリンの市場規模:製品タイプ別、投与経路別、用途別、最終用途別、予測、2023年~2032年

Immunoglobulin Market Size by Product Type (IgG, IgA, IgM), By Route of Administration (Intravenous, Subcutaneous), By Application (Primary Immunodeficiency Disease, Secondary Immunodeficiency Disease) By End-use (Hospitals) & Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 210 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫グロブリンの市場規模:製品タイプ別、投与経路別、用途別、最終用途別、予測、2023年~2032年
出版日: 2023年09月12日
発行: Global Market Insights Inc.
ページ情報: 英文 210 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫グロブリン市場規模は、原発性免疫不全症や二次性免疫不全症を含む免疫不全症の罹患率の上昇により、2023年から2032年にかけて7.7%のCAGRが観察されると予測されています。

国立医学図書館による2021年の報告によると、世界中で600万人以上が原発性免疫不全症に罹患しており、そのうち70%から90%近くは診断されていないです。

様々な自己免疫疾患や炎症性疾患の治療における免疫グロブリンの用途拡大が、市場の成長を後押ししています。バイオテクノロジーの研究開発活動は、革新的な免疫グロブリン製剤のイントロダクションさらに貢献しており、競合情勢を促進しています。

免疫グロブリンA(IgA)は、感染症に対する必要不可欠な防御を提供する免疫システムの主要成分であるため、IgA製品タイプは2032年までに巨額の収益を獲得します。IgAは、呼吸器や消化管などの粘膜組織の感染予防に効果的です。研究が進むにつれて、IgAに基づく治療法は様々な疾患の治療において有望な手段となり、この分野の重要性をさらに確固たるものにしていくと思われます。

多巣性運動ニューロパチー(MMN)セグメントは、2032年まで大幅な成長が見込まれます。筋力低下と萎縮を特徴とする希少な神経疾患であるMMNの有病率の上昇が、免疫グロブリン療法の需要に拍車をかけています。MMNの症状管理における免疫グロブリンの有効性を探る臨床試験や研究活動が進行中であることから、この用途分野は市場にとって有利な手段となる見込みです。

アジア太平洋地域の免疫グロブリン市場は、医療支出の増加、免疫不全疾患の有病率の上昇、高齢化人口の増加により、2023年から2032年にかけて力強いCAGRを記録すると予想されます。さらに、アジア太平洋地域における医療インフラの進歩や、免疫グロブリン療法の利点に関する意識の高まりが、アジア太平洋地域の産業ダイナミクスを形成しています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 免疫グロブリン産業洞察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 高齢者人口の増加
      • 免疫不全疾患の有病率の増加
      • 免疫グロブリンの採用拡大
    • 業界の潜在的リスク&課題
      • 治療費の高騰
      • 厳しい政府規制
  • 成長可能性分析
  • COVID-19影響分析
  • 投与経路比較表
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 免疫グロブリン市場規模・予測:製品タイプ別

  • 主要動向:製品タイプ別
  • IgG
  • IgA
  • IgM
  • IgD
  • IgE

第6章 免疫グロブリン市場規模・予測:投与経路別

  • 主要動向:投与経路別
  • 静脈内投与(IVIG)
  • 皮下投与(SCIg)

第7章 免疫グロブリン市場規模・予測:用途別

  • 主要動向:用途別
  • 慢性炎症性脱髄性多発神経炎(CIDP)
  • 多巣性運動ニューロパチー(MMN)
  • 原発性免疫不全症(PID)
  • 二次性免疫不全症(SID)
  • ギラン・バレー症候群
  • 免疫性血小板減少性紫斑病(ITP)
  • その他

第8章 免疫グロブリン市場規模・予測:最終用途別

  • 主要動向:最終用途別
  • 病院
  • 診療所
  • 在宅医療

第9章 免疫グロブリン市場規模・予測:地域別

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • ポーランド
    • スイス
    • オランダ
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
    • インドネシア
    • ベトナム
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
    • ペルー
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • その他のMEA

第10章 企業プロファイル

  • Baxter international Inc.
  • Johnson & Johnson(Omrix Biopharmaceuticals Inc.)
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Grifols SA
  • Kedrion S.p.A
  • CSL Behring
  • Biotest AG
  • Octapharma AG
  • ADMA Biologics, Inc.
  • Shanghai RAAS Blood Products Co. Ltd
図表

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market revenue, by product type (2022)
  • TABLE 3. Market revenue, by route of administration (2022)
  • TABLE 4. Market share, by application (2022)
  • TABLE 5. Market share, by end-use (2022)
  • TABLE 6. Market share, by region (2022)
  • TABLE 7. Global immunoglobulin market size, 2018-2022, (USD Million)
  • TABLE 8. Global immunoglobulin market size, 2023-2032, (USD Million)
  • TABLE 9. Global immunoglobulin market size, by region, 2018-2022 (USD Million)
  • TABLE 10. Global immunoglobulin market size, by region, 2023-2032 (USD Million)
  • TABLE 11. Global immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 12. Global immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 13. Global immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 14. Global immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 15. Global immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 16. Global immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 17. Global immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 18. Global immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 19. Industry impact forces
  • TABLE 20. IgG market size, 2018-2022 (USD Million)
  • TABLE 21. IgG market size, 2023-2032 (USD Million)
  • TABLE 22. IgA market size, 2018-2022 (USD Million)
  • TABLE 23. IgA market size, 2023-2032 (USD Million)
  • TABLE 24. IgM market size, 2018-2022 (USD Million)
  • TABLE 25. IgM market size, 2023-2032 (USD Million)
  • TABLE 26. IgD market size, 2018-2022 (USD Million)
  • TABLE 27. IgD market size, 2023-2032 (USD Million)
  • TABLE 28. IgE natural polymers market size, 2018-2022 (USD Million)
  • TABLE 29. IgE natural polymers market size, 2023-2032 (USD Million)
  • TABLE 30. Intravenous (IVIG) market size, 2018-2022 (USD Million)
  • TABLE 31. Intravenous (IVIG) market size, 2023-2032 (USD Million)
  • TABLE 32. Subcutaneous (SCIg) market size, 2018-2022 (USD Million)
  • TABLE 33. Subcutaneous (SCIg) market size, 2023-2032 (USD Million)
  • TABLE 34. Chronic inflammatory demyelinating polyneuropathy (CIDP) market size, 2018-2022 (USD Million)
  • TABLE 35. Chronic inflammatory demyelinating polyneuropathy (CIDP) market size, 2023-2032 (USD Million)
  • TABLE 36. Multifocal motor neuropathy (MMN) market size, 2018-2022 (USD Million)
  • TABLE 37. Multifocal motor neuropathy (MMN) market size, 2023-2032 (USD Million)
  • TABLE 38. Primary immunodeficiency disease (PID) market size, 2018-2022 (USD Million)
  • TABLE 39. Primary immunodeficiency disease (PID) market size, 2023-2032 (USD Million)
  • TABLE 40. Secondary immunodeficiency disease (SID) market size, 2018-2022 (USD Million)
  • TABLE 41. Secondary immunodeficiency disease (SID) market size, 2023-2032 (USD Million) ;
  • TABLE 42. Guillain-Barre syndrome market size, 2018-2022 (USD Million)
  • TABLE 43. Guillain-Barre syndrome market size, 2023-2032 (USD Million)
  • TABLE 44. Immune thrombocytopenic purpura (ITP) market size, 2018-2022 (USD Million)
  • TABLE 45. Immune thrombocytopenic purpura (ITP) market size, 2023-2032 (USD Million) ;
  • TABLE 46. Other applications market size, 2018-2022 (USD Million)
  • TABLE 47. Other applications market size, 2023-2032 (USD Million)
  • TABLE 48. Hospitals market size, 2018-2022 (USD Million)
  • TABLE 49. Hospitals market size, 2023-2032 (USD Million)
  • TABLE 50. Clinics market size, 2018-2022 (USD Million)
  • TABLE 51. Clinics market size, 2023-2032 (USD Million) ;
  • TABLE 52. Homecare market size, 2018-2022 (USD Million)
  • TABLE 53. Homecare market size, 2023-2032 (USD Million)
  • TABLE 54. North America immunoglobulin market size, by country, 2018-2022 (USD Million)
  • TABLE 55. North America immunoglobulin market size, by country, 2023-2032 (USD Million)
  • TABLE 56. North America immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 57. North America immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 58. North America immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 59. North America immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 60. North America immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 61. North America immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 62. North America immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 63. North America immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 64. U.S. immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 65. U.S. immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 66. U.S. immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 67. U.S. immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 68. U.S. immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 69. U.S. immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 70. U.S. immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 71. U.S. immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 72. Canada immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 73. Canada immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 74. Canada immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 75. Canada immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 76. Canada immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 77. Canada immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 78. Canada immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 79. Canada immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 80. Europe immunoglobulin market size, by country, 2018-2022 (USD Million)
  • TABLE 81. Europe immunoglobulin market size, by country, 2023-2032 (USD Million)
  • TABLE 82. Europe immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 83. Europe immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 84. Europe immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 85. Europe immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 86. Europe immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 87. Europe immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 88. Europe immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 89. Europe immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 90. Germany immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 91. Germany immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 92. Germany immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 93. Germany immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 94. Germany immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 95. Germany immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 96. Germany immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 97. Germany immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 98. UK immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 99. UK immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 100. UK immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 101. UK immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 102. UK immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 103. UK immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 104. UK immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 105. UK immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 106. France immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 107. France immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 108. France immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 109. France immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 110. France immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 111. France immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 112. France immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 113. France immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 114. Spain immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 115. Spain immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 116. Spain immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 117. Spain immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 118. Spain immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 119. Spain immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 120. Spain immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 121. Spain immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 122. Italy immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 123. Italy immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 124. Italy immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 125. Italy immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 126. Italy immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 127. Italy immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 128. Italy immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 129. Italy immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 130. Poland immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 131. Poland immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 132. Poland immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 133. Poland immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 134. Poland immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 135. Poland immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 136. Poland immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 137. Poland immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 138. Switzerland immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 139. Switzerland immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 140. Switzerland immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 141. Switzerland immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 142. Switzerland immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 143. Switzerland immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 144. Switzerland immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 145. Switzerland immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 146. Netherlands immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 147. Netherlands immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 148. Netherlands immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 149. Netherlands immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 150. Netherlands immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 151. Netherlands immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 152. Netherlands immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 153. Netherlands immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 154. Rest of Europe immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 155. Rest of Europe immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 156. Rest of Europe immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 157. Rest of Europe immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 158. Rest of Europe immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 159. Rest of Europe immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 160. Rest of Europe immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 161. Rest of Europe immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 162. Asia Pacific immunoglobulin market size, by country, 2018-2022 (USD Million)
  • TABLE 163. Asia Pacific immunoglobulin market size, by country, 2023-2032 (USD Million)
  • TABLE 164. Asia Pacific immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 165. Asia Pacific immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 166. Asia Pacific immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 167. Asia Pacific immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 168. Asia Pacific immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 169. Asia Pacific immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 170. Asia Pacific immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 171. Asia Pacific immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 172. China immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 173. China immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 174. China immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 175. China immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 176. China immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 177. China immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 178. China immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 179. China immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 180. Japan immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 181. Japan immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 182. Japan immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 183. Japan immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 184. Japan immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 185. Japan immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 186. Japan immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 187. Japan immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 188. India immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 189. India immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 190. India immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 191. India immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 192. India immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 193. India immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 194. India immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 195. India immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 196. Australia immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 197. Australia immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 198. Australia immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 199. Australia immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 200. Australia immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 201. Australia immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 202. Australia immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 203. Australia immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 204. South Korea immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 205. South Korea immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 206. South Korea immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 207. South Korea immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 208. South Korea immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 209. South Korea immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 210. South Korea immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 211. South Korea immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 212. Thailand immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 213. Thailand immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 214. Thailand immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 215. Thailand immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 216. Thailand immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 217. Thailand immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 218. Thailand immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 219. Thailand immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 220. Indonesia immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 221. Indonesia immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 222. Indonesia immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 223. Indonesia immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 224. Indonesia immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 225. Indonesia immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 226. Indonesia immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 227. Indonesia immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 228. Vietnam immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 229. Vietnam immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 230. Vietnam immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 231. Vietnam immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 232. Vietnam immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 233. Vietnam immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 234. Vietnam immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 235. Vietnam immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 236. Rest of Asia Pacific immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 237. Rest of Asia Pacific immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 238. Rest of Asia Pacific immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 239. Rest of Asia Pacific immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 240. Rest of Asia Pacific immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 241. Rest of Asia Pacific immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 242. Rest of Asia Pacific immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 243. Rest of Asia Pacific immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 244. Latin America immunoglobulin market size, by country, 2018-2022 (USD Million)
  • TABLE 245. Latin America immunoglobulin market size, by country, 2023-2032 (USD Million)
  • TABLE 246. Latin America immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 247. Latin America immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 248. Latin America immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 249. Latin America immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 250. Latin America immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 251. Latin America immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 252. Latin America immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 253. Latin America immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 254. Brazil immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 255. Brazil immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 256. Brazil immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 257. Brazil immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 258. Brazil immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 259. Brazil immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 260. Brazil immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 261. Brazil immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 262. Mexico immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 263. Mexico immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 264. Mexico immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 265. Mexico immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 266. Mexico immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 267. Mexico immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 268. Mexico immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 269. Mexico immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 270. Argentina immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 271. Argentina immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 272. Argentina immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 273. Argentina immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 274. Argentina immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 275. Argentina immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 276. Argentina immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 277. Argentina immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 278. Colombia immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 279. Colombia immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 280. Colombia immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 281. Colombia immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 282. Colombia immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 283. Colombia immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 284. Colombia immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 285. Colombia immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 286. Chile immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 287. Chile immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 288. Chile immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 289. Chile immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 290. Chile immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 291. Chile immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 292. Chile immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 293. Chile immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 294. Peru immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 295. Peru immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 296. Peru immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 297. Peru immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 298. Peru immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 299. Peru immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 300. Peru immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 301. Peru immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 302. Rest of Latin America immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 303. Rest of Latin America immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 304. Rest of Latin America immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 305. Rest of Latin America immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 306. Rest of Latin America immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 307. Rest of Latin America immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 308. Rest of Latin America immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 309. Rest of Latin America immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 310. Middle East & Africa (MEA) immunoglobulin market size, by country, 2018-2022 (USD Million)
  • TABLE 311. Middle East & Africa (MEA) immunoglobulin market size, by country, 2023-2032 (USD Million)
  • TABLE 312. Middle East & Africa (MEA) immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 313. Middle East & Africa (MEA) immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 314. Middle East & Africa (MEA) immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 315. Middle East & Africa (MEA) immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 316. Middle East & Africa (MEA) immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 317. Middle East & Africa (MEA) immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 318. Middle East & Africa (MEA) immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 319. Middle East & Africa (MEA) immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 320. South Africa immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 321. South Africa immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 322. South Africa immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 323. South Africa immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 324. South Africa immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 325. South Africa immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 326. South Africa immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 327. South Africa immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 328. Saudi Arabia immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 329. Saudi Arabia immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 330. Saudi Arabia immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 331. Saudi Arabia immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 332. Saudi Arabia immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 333. Saudi Arabia immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 334. Saudi Arabia immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 335. Saudi Arabia immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 336. UAE immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 337. UAE immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 338. UAE immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 339. UAE immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 340. UAE immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 341. UAE immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 342. UAE immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 343. UAE immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 344. Israel immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 345. Israel immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 346. Israel immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 347. Israel immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 348. Israel immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 349. Israel immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 350. Israel immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 351. Israel immunoglobulin market size, by end-use, 2023-2032 (USD Million)
  • TABLE 352. Rest of MEA immunoglobulin market size, by product type, 2018-2022 (USD Million)
  • TABLE 353. Rest of MEA immunoglobulin market size, by product type, 2023-2032 (USD Million)
  • TABLE 354. Rest of MEA immunoglobulin market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 355. Rest of MEA immunoglobulin market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 356. Rest of MEA immunoglobulin market size, by application, 2018-2022 (USD Million)
  • TABLE 357. Rest of MEA immunoglobulin market size, by application, 2023-2032 (USD Million)
  • TABLE 358. Rest of MEA immunoglobulin market size, by end-use, 2018-2022 (USD Million)
  • TABLE 359. Rest of MEA immunoglobulin market size, by end-use, 2023-2032 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Top-down approach
  • FIG. 3 Market estimation and forecast methodology
  • FIG. 4 Market forecasting methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Immunoglobulin industry, 360 degree synopsis, 2018 - 2032
  • FIG. 7 Industry landscape, 2018-2032 (USD Million)
  • FIG. 8 Growth potential analysis, by product type
  • FIG. 9 Growth potential analysis, by route of administration
  • FIG. 10 Growth potential analysis, by application
  • FIG. 11 Growth potential analysis, by end-use
  • FIG. 12 Porter's analysis
  • FIG. 13 PESTEL analysis
  • FIG. 14 Company matrix analysis, 2022
  • FIG. 15 Strategy dashboard, 2022
目次
Product Code: 5752

Immunoglobulin market size is predicted to observe 7.7% CAGR during 2023 and 2032 owing to the escalating incidence of immunodeficiency disorders, including primary immunodeficiency diseases and secondary immunodeficiency diseases. According to a 2021 report by National Library of Medicine, more than 6 million people across the globe are affected by primary immunodeficiencies, of which nearly 70% to 90% are not diagnosed.

The expanding applications of immunoglobulin in treating various autoimmune and inflammatory diseases is bolstering market growth. The ongoing R&D activities in biotechnology are further contributing to the introduction of innovative immunoglobulin products, fostering a competitive market landscape.

The overall immunoglobulin industry is classified based on product type, route of administration, application, end-use, and region.

The IgA product type segment will garner massive revenues by 2032 as immunoglobulin A (IgA) is a key component of the immune system which provides essential defense against infections. IgA is effective in preventing infections in mucosal tissues such as the respiratory and gastrointestinal tracts. As research advances, IgA-based therapies will emerge as a promising avenue in the treatment of various diseases, further solidifying the significance of this segment.

The multifocal motor neuropathy (MMN) segment is anticipated to witness substantial growth through 2032. The rising prevalence of MMN, a rare neurological disorder characterized by muscle weakness and atrophy, is fueling the demand for immunoglobulin therapies. With ongoing clinical trials and research endeavors exploring the efficacy of immunoglobulins in managing MMN symptoms, this application segment is poised to be a lucrative avenue for the market.

Asia Pacific immunoglobulin market is expected to record strong CAGR from 2023 to 2032 owing to the increasing healthcare expenditure, rising prevalence of immunodeficiency disorders, and a growing aging population. Moreover, advancements in the healthcare infrastructure across the region and a surge in awareness regarding the benefits of immunoglobulin therapies are shaping the Asia Pacific industry dynamics.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Immunoglobulin industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Product type trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Application trends
    • 2.1.6 End-use trends

Chapter 3 Immunoglobulin Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing geriatric population
      • 3.2.1.2 Increasing prevalence of immunodeficiency diseases
      • 3.2.1.3 Growing adoption of immunoglobulin
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of therapy
      • 3.2.2.2 Stringent government regulations
  • 3.3 Growth potential analysis
    • 3.3.1 By product type
    • 3.3.2 By route of administration
    • 3.3.3 By application
    • 3.3.4 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Route of administration comparison table
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Immunoglobulin Market Size and Forecast, By Product Type (USD Million)

  • 5.1 Key trends, by product type
  • 5.2 IgG
  • 5.3 IgA
  • 5.4 IgM
  • 5.5 IgD
  • 5.6 IgE

Chapter 6 Immunoglobulin Market Size and Forecast, By Route of Administration (USD Million)

  • 6.1 Key trends, by route of administration
  • 6.2 Intravenous (IVIG)
  • 6.3 Subcutaneous (SCIg)

Chapter 7 Immunoglobulin Market Size and Forecast, By Application (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • 7.3 Multifocal motor neuropathy (MMN)
  • 7.4 Primary immunodeficiency disease (PID)
  • 7.5 Secondary immunodeficiency disease (SID)
  • 7.6 Guillain-Barre syndrome
  • 7.7 Immune thrombocytopenic purpura (ITP)
  • 7.8 Other applications

Chapter 8 Immunoglobulin Market Size and Forecast, By End-use (USD Million)

  • 8.1 Key trends, by end-use
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Homecare

Chapter 9 Immunoglobulin Market Size and Forecast, By Region (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Poland
    • 9.3.7 Switzerland
    • 9.3.8 Netherlands
    • 9.3.9 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Thailand
    • 9.4.7 Indonesia
    • 9.4.8 Vietnam
    • 9.4.9 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Columbia
    • 9.5.5 Chile
    • 9.5.6 Peru
    • 9.5.7 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Israel
    • 9.6.5 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 Baxter international Inc.
  • 10.2 Johnson & Johnson (Omrix Biopharmaceuticals Inc.)
  • 10.3 Pfizer Inc.
  • 10.4 Takeda Pharmaceutical Company Limited
  • 10.5 Grifols SA
  • 10.6 Kedrion S.p.A
  • 10.7 CSL Behring
  • 10.8 Biotest AG
  • 10.9 Octapharma AG
  • 10.10 ADMA Biologics, Inc.
  • 10.11 Shanghai RAAS Blood Products Co. Ltd